Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - UC DAVIS
This study is looking for women, especially those who are obese, to help test new birth control options that aim to prevent unintended pregnancies while keeping safety in mind, so you can have choices that work better for your health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11127344 on NIH RePORTER |
What this research studies
This research focuses on creating new contraceptive options that effectively prevent unintended pregnancies while also minimizing the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) will develop and implement clinical trial protocols aimed at testing these new contraceptive methods. By involving women with various health conditions, the research seeks to ensure that the new contraceptives are safe and effective for a broader population. Participants may have the opportunity to contribute to the development of contraceptives that better meet their needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include women seeking effective contraception, especially those who are obese or have medical conditions that make current contraceptive options unsuitable.
Not a fit: Patients who are not seeking contraception or who do not have any health conditions that affect contraceptive use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective contraceptive options for women, particularly those at higher risk due to obesity.
How similar studies have performed: Previous research in contraceptive development has shown promise in creating safer options, indicating that this approach has potential for success.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Creinin, Mitchell — University of California at Davis
- Study coordinator: Creinin, Mitchell
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.